The Latest

Medical device and pharma news and information

Medical Device and Pharmaceutical News

The latest information of interest to regulated industry. Bookmark this page to have a quick review for

    • FDA enforcement news
    • Regulatory updates
    • Innovative products
    • Compliance information, and
    • Other industry headlines.

And do not forget to check our pages for consumer safety information and regulatory services.

Eight Months of Moringa Salmonella Outbreaks

Recurring Salmonella Outbreaks Raise Questions About Supplement Oversight Since November 2025, the U.S. Food and Drug Administration has investigated and coordinated multiple recalls involving moringa dietary supplements contaminated with Salmonella. What initially...

read more

FDA Closes Moringa Salmonella Outbreak Investigation

The U.S. Food and Drug Administration and the Centers for Disease Control and Prevention have concluded their investigation into a multistate Salmonella Typhimurium outbreak linked to MOGO-brand moringa powder capsules distributed by MOGO Moringa LLC of St. Louis,...

read more

FDA Early Alert for Baxter Intravascular Administration Sets

Healthcare facilities are instructed to immediately stop using affected IV solution sets while FDA evaluates the potentially high-risk device issueThe U.S. Food and Drug Administration (FDA) has issued an Early Alert regarding certain Baxter Duo-Vent Solution Sets...

read more

Why the Sudden Focus on Testosterone?

New Military Screening Program Raises Questions About Science, Strategy and TransparencyThe Trump administration's decision to begin annual testosterone screening for active-duty and reserve service members age 30 and older has generated headlines and a growing number...

read more

Arrow Corrects Kits With Recalled Injectable Medications

FDA Classifies Field Correction As Class I Recall Due to Risk of Serious Injury The U.S. Food and Drug Administration (FDA) has classified a correction issued by Arrow International, a subsidiary of Teleflex, as a Class I recall after certain convenience kits were...

read more

Casgevy Gene Therapy Expanded to 2-Year-Old Children

FDA Expands Casgevy Gene Therapy Approval to Children as Young as 2 with Sickle Cell DiseaseFirst CRISPR-based gene therapy approved for young children with sickle cell disease The U.S. Food and Drug Administration (FDA) has approved an expanded indication for Casgevy...

read more

FDA Issues Early Alert for Resmed Astral Ventilators

Resmed VentilatorPatients should continue using devices unless instructed otherwise by their healthcare provider The U.S. Food and Drug Administration (FDA) has issued an Early Alert regarding a potentially high-risk issue affecting certain Resmed Astral 100 and...

read more